Scarica l'app Stockscreener
128.85
0.04%
0.05
Pre-mercato:
132.81
3.96
+3.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$128.80
Aprire:
$127.97
Volume 24 ore:
9.71M
Relative Volume:
0.98
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.88%
1M Prestazione:
+3.91%
6M Prestazione:
+24.28%
1 anno Prestazione:
+76.53%
Intervallo 1D:
$126.37
$129.22
Intervallo di 1 settimana:
$125.57
$131.45
Portata 52W:
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Nome
State Street Spdr S P Biotech Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
128.85 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
325.43 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
659.22 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
662.38 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
265.55 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
588.59 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Borsa (XBI) Ultime notizie
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - ca.finance.yahoo.com
Neurocrine Buys Soleno To Tap High-Growth Rare Disease MarketNeurocrine Biosciences (NASDAQ:NBIX), Sol - Benzinga
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 24/7 Wall St.
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today - Sahm
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Trade State Street SPDR S&P Biotech ETFXBI CFD - Capital.com
Atika Capital Management LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Moderna, Inc. Stocks - TradingView
ADMA Jumps 15% in Late-Day Rally: Biotech Market Turbulence Escalates Amid Options Trading Momentum - Bitget
Is State Street SPDR S&P Biotech ETF (XBI) a strong ETF right now? - MSN
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
US defense giant taps Israeli drone navigation tech built for jammed battlefields - The Jerusalem Post
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Scholar Rock Holding Surges 10.6% in Intraday Trade – What’s Behind the Volatility? - Bitget
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Biotech ETF with a twist: Defiance to donate initial advisory profits to autism causes - MSN
Autocall Notes Linked to Nasdaq-100 & ETFs (AMJB) — $3M Offering - Stock Titan
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
XBI: Biotech M&A Has Been Hot, But Price Trends Have Cooled - Seeking Alpha
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
This 1 ETF Keeps Outperforming the S&P 500- Expect it to Win Again This Year - AOL.com
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Moderna, Mexico Partner To Boost Local Vaccine ProductionModerna (NASDAQ:MRNA) - Benzinga
Investors Are Flocking to This ETF. It Could Outperform the S&P 500 for Years. - AOL.com
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
State Street Spdr S P Biotech Etf Azioni (XBI) Dati Finanziari
Non sono disponibili dati finanziari per State Street Spdr S P Biotech Etf (XBI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):